alanylglutamine has been researched along with Impaired Glucose Tolerance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allaouchiche, B; Barnoud, D; Bleichner, G; Coëffier, M; Cohendy, R; Colas, G; Cynober, L; Czernichow, P; Déchelotte, P; Guillou, YM; Hasselmann, M; Hecketsweiler, B; Mansoor, O; Mazerolles, M; Merle, V; Petit, J; Samba, D | 1 |
| Avenell, A; Noble, DW | 1 |
1 trial(s) available for alanylglutamine and Impaired Glucose Tolerance
| Article | Year |
|---|---|
L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study.
Topics: Analysis of Variance; Critical Care; Cross Infection; Dietary Supplements; Dipeptides; Double-Blind Method; Female; France; Glucose Intolerance; Glutamine; Humans; Male; Middle Aged; Parenteral Nutrition, Total; Prospective Studies; Survival Rate | 2006 |
1 other study(ies) available for alanylglutamine and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Glutamine-containing parenteral nutrition: Another piece in the jigsaw?
Topics: Critical Care; Cross Infection; Dietary Supplements; Dipeptides; Glucose Intolerance; Glutamine; Humans; Parenteral Nutrition, Total | 2006 |